Elegen is blazing a path towards a biology-based economy with a highly innovative approach to DNA synthesis that delivers an industry leading length of 7kb in 7 business days with a 99.999% per base accuracy. Our multidisciplinary team of best-in-class biologists, chemists, hardware, and software engineers apply cutting-edge technologies and methods to solve critical bottlenecks in synthetic biology workflows to help our customers in pharma, biotech, agbio, and biomanufacturing streamline their work and realize the full potential of programmable biology.
Elegen is a rising star in the synthetic biology industry. After recently closing a Series B funding round and signing a licensing and collaboration agreement with GSK, they are poised to disrupt the research and clinical synthetic DNA supply markets, delivering next-gen gene synthesis solutions from their patented cell-free synthesis and cloning technologies.
We are seeking an experienced, passionate business development lead for Europe to build and drive growth for Elegen’s transformative synthetic DNA products. You will be accountable for using your knowledge of Elegen’s offerings, competitor products, and the broader synthetic DNA market to develop and manage key relationships that result in the achievement of sales targets.
This is a rare and exciting opportunity to be part of a uniquely innovative, rapidly moving, high impact start-up. In addition to revolutionizing the market for synthetic DNA, you will be part of establishing a strong culture of mutual respect, integrity, and collaboration while working alongside some of Silicon Valley’s best. This is a unique opportunity to be the first European based hire for Elegen’ s commercial team.
Essential Responsibilities:
Essential Candidate Profile:
Preferred Experience:
About The Company:
Founded and led by Dr. Matthew Hill and located in San Carlos, CA, Elegen is well-capitalized by top life science investors, including Andreessen Horowitz, 8VC, and KdT. The company is advised and staffed by leading biotechnology scientists and entrepreneurs, including Dr. Marc Unger, inventor of the Nanoflex™ valve, and former CSO of Fluidigm. Dr. Hill has a PhD from Stanford and a proven track record of advancing innovative technologies from invention to commercial success. Over eight years in his previous role as VP of R&D at a leading molecular diagnostics company, he co-invented and launched five precision molecular diagnostic products, including a best-in-class noninvasive prenatal test used by millions. These products earn more than $350 million per year in revenue and enabled an IPO.
Elegen is an Equal Opportunity Employer.
Elegen provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, genetic characteristics, or any other category protected by law. All applicants have rights under the following Federal Employment Laws:
Last updated on Aug 27, 2024
San Carlos, California
·30+ days ago
San Carlos, California
·30+ days ago
San Carlos, California
·30+ days ago
San Carlos, California
·30+ days ago
San Carlos, California
·30+ days ago
Palo Alto, California
·30+ days ago
Atlanta, Georgia
·30+ days ago
Remote
·30+ days ago
Remote
·30+ days ago
East Windsor, New Jersey
·30+ days ago
Remote
·30+ days ago
Glendale, California
·30+ days ago
Remote
·30+ days ago
New York, New York
·30+ days ago
Chicago, Illinois
·30+ days ago